CoChat

Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays

Open access
Vandeputte, Marthe M., Persson, Mattias, Walther, Donna, Vikingsson, Svante, Kronstrand, Robert, Baumann, Michael H., Gréen, Henrik, Stove, Christophe P. · 2022 · Archives of Toxicology
Cited by 24

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

New synthetic opioids (NSOs) are one of the fastest growing groups of new psychoactive substances. Amid this dynamic landscape, insight into the pharmacology of NSOs is important to estimate the harm potential of newly emerging drugs. In this work, we determined the µ-opioid receptor (MOR) affinity and activation potential of seven poorly characterized non-fentanyl NSOs (N-ethyl-U-47700, 3,4-difluoro-U-47700, U-47931E/bromadoline, 2,4-difluoro-U-48800, U-62066/spiradoline, 2F-viminol, ketobemidone) and a panel of nine reference opioids. MOR affinity was determined via [3H]-DAMGO binding in rat brain tissue homogenates, and was found to correlate well with different functional parameters. MOR activation potential was studied at different levels of receptor signaling using three distinct assays (NanoBiT® MOR-β-arrestin2/mini-Gαi and AequoScreen®). The most active compounds were ketobemidone (EC50 32.8–528 nM; Emax 105–271%, relative to hydromorphone) and N-ethyl-U-47700 (EC50 241–767 nM; Emax 139–247%). The same opioids showed the strongest MOR affinity. As most of the other NSOs only weakly activated MOR in the three assays (EC50 values in the high nM–µM range), they likely do not pose a high overdose risk. 2F-viminol (EC50 2.2–4.5 µM; Emax 21.2–61.5%) and U-47931E/bromadoline (EC50 0.55–2.9 µM; Emax 52.8–85.9%) were partial agonists compared to hydromorphone, and maximum receptor activation was not reached for 2,4-difluoro-U-48800 (EC50 > 22 µM). We further highlight the importance of considering specific assay characteristics upon interpretation of potencies, efficacies and biased agonism. As absolute values may greatly differ between assays with varying experimental set-ups, a comparison of functional parameters to those of well-characterized reference agonists is considered the most informative.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00204-021-03207-9

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 24

Metadata

Authors
Vandeputte, M. M., Persson, M., Walther, D., Vikingsson, S., Kronstrand, R., Baumann, M. H., Gréen, H., & Stove, C. P.
Venue
Archives of Toxicology
Published
2022-01-24
Volume
96
Issue
3
Pages
877-897
ISSN
  • 0340-5761 (ISSN-L)
  • 1432-0738
OpenAlex
W4207045874
Cited by
24
References
9
FWCI
12.52
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays. https://app.cochat.ai/papers/10.1007/s00204-021-03207-9
The paper
Vandeputte, M. M., Persson, M., Walther, D., Vikingsson, S., Kronstrand, R., Baumann, M. H., Gréen, H., & Stove, C. P. (2022). Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays. Archives of Toxicology. https://doi.org/10.1007/s00204-021-03207-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.